AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Clinical trial NCT00243061 · COMPLETED

Trial details

NCT number: NCT00243061
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acral Lentiginous Malignant Melanoma Ciliary Body and Choroid Melanoma, Medium/Large Size Ciliary Body and Choroid Melanoma, Small Size Extraocular Extension Melanoma Intraocular Melanoma Iris Melanoma Lentigo Maligna Malignant Melanoma Recurrent Melanoma Stage, Intraocular Melanoma Stage IV Melanoma Superficial Spreading Malignant Melanoma

Start date: 2006-01-01
Primary completion: 2012-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.